Section of Advanced Endoscopy, The Ohio State University Wexner Medical Center, Columbus, Ohio; Section of Pancreatic Disorders, Division of Gastroenterology, Hepatology & Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Clin Gastroenterol Hepatol. 2016 Jul;14(7):1001-1010.e5. doi: 10.1016/j.cgh.2016.02.015. Epub 2016 Feb 22.
BACKGROUND & AIMS: The prevalence of obesity and number of patients undergoing bariatric surgery are increasing. Obesity has adverse effects in patients with acute pancreatitis (AP). We investigated whether bariatric surgery affects outcomes of patients with AP.
We performed a retrospective study, collecting data from the US Nationwide Inpatient Sample (2007-2011) on all adult inpatients (≥18 years) with a principal diagnosis of AP (n = 1,342,681). We compared primary clinical outcomes (mortality, acute kidney injury, and respiratory failure) and secondary outcomes related to healthcare resources (hospital stay and charges) among patient groups using univariate and multivariate analyses. We performed a propensity score-matched analysis to compare outcomes of patients with versus without bariatric surgery.
Of patients admitted to the hospital with a principal diagnosis of AP, 14,332 (1.07%) had undergone bariatric surgery. The number of patients that underwent bariatric surgery doubled, from 1801 in 2007 to 3928 in 2011 (P < .001). AP in patients that had undergone bariatric surgery was most frequently associated with gallstones. Multivariate analysis associated prior bariatric surgery with decreased mortality (odds ratio, 0.41; 95% confidence interval, 0.18-0.92), shorter duration of hospitalization (0.65 days shorter; P < .001), and lower hospital charges ($3558 lower) than in patients with AP not receiving bariatric surgery (P < .001). A propensity score-matched cohort analysis found that mortality and odds of acute kidney injury were similar between patients with versus without history of bariatric surgery, whereas respiratory failure was less frequent in patients who received bariatric surgery (1.34% vs 4.42%; P < .001).
Prior bariatric surgery in patients hospitalized with AP is not adversely associated with in-hospital mortality, development of organ failure, or healthcare resource use. Bariatric surgery may mitigate the obesity-associated adverse prognostication in AP. These observations are pertinent for future research, because the prevalence of obesity and AP-related hospitalizations is increasing.
肥胖的流行率和接受减重手术的患者数量都在增加。肥胖对急性胰腺炎(AP)患者有不良影响。我们研究了减重手术是否会影响 AP 患者的结局。
我们进行了一项回顾性研究,从美国全国住院患者样本(2007-2011 年)中收集了所有主要诊断为 AP(n=1342681 名)的成年住院患者的数据。我们使用单变量和多变量分析比较了患者组的主要临床结局(死亡率、急性肾损伤和呼吸衰竭)和与医疗资源相关的次要结局(住院时间和费用)。我们进行了倾向评分匹配分析,以比较接受和未接受减重手术患者的结局。
在因主要诊断为 AP 而住院的患者中,有 14332 例(1.07%)接受了减重手术。接受减重手术的患者数量翻了一番,从 2007 年的 1801 例增加到 2011 年的 3928 例(P<.001)。接受减重手术的 AP 患者最常与胆结石相关。多变量分析表明,与未接受减重手术的 AP 患者相比,既往减重手术与死亡率降低(比值比,0.41;95%置信区间,0.18-0.92)、住院时间缩短(0.65 天;P<.001)和住院费用降低(3558 美元;P<.001)相关。倾向评分匹配队列分析发现,有和无减重手术史的患者的死亡率和急性肾损伤发生率相似,而接受减重手术的患者呼吸衰竭的发生率较低(1.34% vs 4.42%;P<.001)。
AP 住院患者既往有减重手术史与院内死亡率、器官衰竭的发生或医疗资源的使用无关。减重手术可能减轻肥胖对 AP 预后不良的影响。这些观察结果与未来的研究相关,因为肥胖的流行率和与 AP 相关的住院率正在增加。